Morgan Stanley flags Amgen's edge after heart-drug rival stumbles
A private meeting with Amgen management left Morgan Stanley with a very different read than the broader market’s.
We can't find the internet
Attempting to reconnectSomething went wrong!
Attempting to reconnectA private meeting with Amgen management left Morgan Stanley with a very different read than the broader market’s.
Today reads warmer than 0 of the last 11 scored days. Click a bar to read that day's stories.